IMO-2125

Idera Drug Combo Does Well In Early Study
Investopedia
Wed, 03/1/17 - 09:59 am
Idera
clinical trials
IMO-2125
metastatic melanoma
Idera Pharmaceuticals Delays Initiation of Phase 2 Clinical Trial of IMO-2125 in Treatment-Naïve HCV Patients
Yahoo/BusinessWire
Sat, 04/23/11 - 10:47 am
Idera Pharmaceuticals
IMO-2125
HCV
toll-like Receptor (TLR) 9 agonist
Idera Pharmaceuticals Presents Data from a Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients at EASL 2011
Yahoo/BusinessWire
Sat, 04/2/11 - 10:22 am
Idera Pharmaceuticals
IMO-2125
HCV
Idera Pharmaceuticals Presents Phase 1 Data on IMO-2125 Demonstrating Induction of Broad Antiviral Immune Response in Null-Responder HCV Patients
Yahoo/BusinessWire
Sat, 10/30/10 - 12:23 pm
Idera Pharmaceuticals
IMO-2125
hepatitis C